Cocarcinogenic effect of capsaicin involves activation of EGFR signaling but not TRPV1

Cancer Research

Volumn 70, Issue 17, 2010, Pages 6859-6869

  Hwang, Mun Kyung ^a,b,c   Bode, Ann M ^c   Byun, Sanguine ^a,b,c   Song, Nu Ry ^b,c   Joo Lee, Hyong ^b   Lee, Ki Won ^a   Dong, Zigang ^c  

^a Konkuk University   (South Korea)

^b Seoul National University   (South Korea)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; 7,12 DIMETHYLBENZ[A]ANTHRACENE; CAPSAICIN; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; ILOMASTAT; MATRIX METALLOPROTEINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE B; VANILLOID RECEPTOR 1; PROTEIN TYROSINE KINASE; TRPV1 PROTEIN, MOUSE; VANILLOID RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; GENE ACTIVATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SKIN CARCINOGENESIS; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED; COCARCINOGENESIS; DEFICIENCY; DRUG EFFECTS; DRUG POTENTIATION; FEMALE; KNOCKOUT MOUSE; MALE; METABOLISM; SIGNAL TRANSDUCTION; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TOXICITY; TUMOR CELL LINE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CAPSAICIN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; COCARCINOGENESIS; CYCLOOXYGENASE 2; DRUG SYNERGISM; ENZYME ACTIVATION; FEMALE; HUMANS; MALE; MICE; MICE, KNOCKOUT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; SRC-FAMILY KINASES; TETRADECANOYLPHORBOL ACETATE; TRPV CATION CHANNELS;

EID: 77956271267     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-4393     Document Type: Article

References (50)

1. Ito K, Nakazato T, Yamato K, et al. Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: implication of phosphorylation of p53 at Ser-15 residue by reactive oxygen species. Cancer Res 2004;64:1071-8. (Pubitemid 38176912)
2. Lee YS, Kang YS, Lee JS, Nicolova S, Kim JA. Involvement of NADPH oxidase-mediated generation of reactive oxygen species in the apoptotic cell death by capsaicin in HepG2 human hepatoma cells. Free Radic Res 2004;38:405-12.
3. Kim YM, Hwang JT, Kwak DW, Lee YK, Park OJ. Involvement of AMPK signaling cascade in capsaicin-induced apoptosis of HT-29 colon cancer cells. Ann N Y Acad Sci 2007;1095:496-503.
4. Surh YJ, Lee SS. Capsaicin in hot chili pepper: carcinogen, co-carcinogen or anticarcinogen? Food Chem Toxicol 1996;34:313-6.
5. Agrawal RC, Wiessler M, Hecker E, Bhide SV. Tumour-promoting effect of chilli extract in BALB/c mice. Int J Cancer 1986;38:689-95. (Pubitemid 17189128)
6. Toth B, Rogan E, Walker B. Tumorigenicity and mutagenicity studies with capsaicin of hot peppers. Anticancer Res 1984;4:117-9.
7. Lopez-Carrillo L, Lopez-Cervantes M, Robles-Diaz G, et al. Capsaicin consumption, Helicobacter pylori positivity and gastric cancer in Mexico. Int J Cancer 2003;106:277-82. (Pubitemid 36835183)
8. Erin N, Zhao W, Bylander J, Chase G, Clawson G. Capsaicin-induced inactivation of sensory neurons promotes a more aggressive gene expression phenotype in breast cancer cells. Breast Cancer Res Treat 2006;99:351-64.
9. Malagarie-Cazenave S, Olea-Herrero N, Vara D, Diaz-Laviada I. Capsaicin, a component of red peppers, induces expression of androgen receptor via PI3K and MAPK pathways in prostate LNCaP cells. FEBS Lett 2009;583:141-7.
10. Szallasi A, Cortright DN, Blum CA, Eid SR. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov 2007;6:357-72.
11. Messeguer A, Planells-Cases R, Ferrer-Montiel A. Physiology and pharmacology of the vanilloid receptor. Curr Neuropharmacol 2006;4:1-15.
12. Prevarskaya N, Zhang L, Barritt G. TRP channels in cancer. Biochim Biophys Acta 2007;1772:937-46.
13. Lazzeri M, Vannucchi MG, Spinelli M, et al. Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder. Eur Urol 2005;48:691-8. (Pubitemid 41278598)
14. Amantini C, Mosca M, Nabissi M, et al. Capsaicin-induced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation. J Neurochem 2007;102:977-90.
15. Bode AM, Cho YY, Zheng D, et al. Transient receptor potential type vanilloid 1 suppresses skin carcinogenesis. Cancer Res 2009;69: 905-13.
16. Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007; 26:3291-310.
17. Kang NJ, Lee KW, Rogozin EA, et al. Equol, a metabolite of the soybean isoflavone daidzein, inhibits neoplastic cell transformation by targeting the MEK/ERK/p90RSK/activator protein-1 pathway. J Biol Chem 2007;282:32856-66.
18. Lee KW, Kang NJ, Heo YS, et al. Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. Cancer Res 2008;68:946-55.
19. el-Marjou A, Delouvee A, Thiery JP, Radvanyi F. Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression. Carcinogenesis 2000;21:2211-8.
20. Dannenberg AJ, Subbaramaiah K. Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. Cancer Cell 2003;4:431-6. (Pubitemid 38050040)
21. Dannenberg AJ, Lippman SM, Mann JR, Subbaramaiah K, DuBois RN. Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention. J Clin Oncol 2005;23: 254-66.
22. Zhao Y, He D, Saatian B, et al. Regulation of lysophosphatidic acid-induced epidermal growth factor receptor transactivation and interleukin-8 secretion in human bronchial epithelial cells by protein kinase Cδ, Lyn kinase, and matrix metalloproteinases. J Biol Chem 2006;281:19501-11.
23. Lin SY, Makino K, Xia W, et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 2001; 3:802-8. (Pubitemid 32842685)
24. Caterina MJ, Leffler A, Malmberg AB, et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000; 288:306-13. (Pubitemid 30226186)
25. Kim SR, Kim SU, Oh U, Jin BK. Transient receptor potential vanilloid subtype 1 mediates microglial cell death in vivo and in vitro via Ca2+-mediated mitochondrial damage and cytochrome c release. J Immunol 2006;177:4322-9.
26. Motter AL, Ahern GP.TRPV1-null mice are protected from diet-induced obesity. FEBS Lett 2008;582:2257-62.
27. Wang S, Davis BM, Zwick M, Waxman SG, Albers KM. Reduced thermal sensitivity and Nav1.8 and TRPV1 channel expression in sensory neurons of aged mice. Neurobiol Aging 2006;27:895-903.
28. Southall MD, Li T, Gharibova LS, Pei Y, Nicol GD, Travers JB. Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. J Pharmacol Exp Ther 2003;304:217-22. (Pubitemid 36008931)
29. Lee YM, Kim YK, Kim KH, Park SJ, Kim SJ, Chung JH. A novel role for the TRPV1 channel in UV-induced matrix metalloproteinase (MMP)-1 expression in HaCaT cells. J Cell Physiol 2009;219:766-75.
30. Pecze L, Szabo K, Szell M, et al. Human keratinocytes are vanilloid resistant. PLoS One 2008;3:e3419.
31. Geppetti P, Trevisani M. Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function. Br J Pharmacol 2004;141:1313-20.
32. Alawi K, Keeble J. The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation. Pharmacol Ther 2009; 125:181-95.
33. Massa F, Sibaev A, Marsicano G, Blaudzun H, Storr M, Lutz B. Vanilloid receptor (TRPV1)-deficient mice show increased susceptibility to dinitrobenzene sulfonic acid induced colitis. J Mol Med 2006; 84:142-6. (Pubitemid 43201254)
34. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001;2:127-37.
35. Chen X, Resh MD. Cholesterol depletion from the plasma membrane triggers ligand-independent activation of the epidermal growth factor receptor. J Biol Chem 2002;277:49631-7.
36. Simeonova PP, Wang S, Hulderman T, Luster MI. c-Src-dependent activation of the epidermal growth factor receptor and mitogen-activated protein kinase pathway by arsenic. Role in carcinogenesis. J Biol Chem 2002;277:2945-50. (Pubitemid 34953329)
37. Serra I, Yamamoto M, Calvo A, et al. Association of chili pepper consumption, low socioeconomic status and longstanding gallstones with gallbladder cancer in a Chilean population. Int J Cancer 2002; 102:407-11.
38. Liang Z, Zeng X, Gao J, et al. Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinoma from Chinese patients. BMC Cancer 2008;8:363.
39. Kim MA, Lee HS, Lee HE, Jeon YK, Yang HK, Kim WH. EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number. Histopathology 2008;52:738-46.
40. Kaufman M, Mehrotra B, Limaye S, et al. EGFR expression in gallbladder carcinoma in North America. Int J Med Sci 2008;5:285-91.
41. Aggarwal BB, Kunnumakkara AB, Harikumar KB, Tharakan ST, Sung B, Anand P. Potential of spice-derived phytochemicals for cancer prevention. Planta Med 2008;74:1560-9.
42. Amantini C, Ballarini P, Caprodossi S, et al. Triggering of transient receptor potential vanilloid type 1 (TRPV1) by capsaicin induces Fas/CD95-mediated apoptosis of urothelial cancer cells in an ATM-dependent manner. Carcinogenesis 2009;30:1320-9.
43. Singh S, Natarajan K, Aggarwal BB. Capsaicin (8-methyl-N-vanillyl- 6-nonenamide) is a potent inhibitor of nuclear transcription factor-κB activation by diverse agents. J Immunol 1996;157:4412-20. (Pubitemid 126449359)
44. Han SS, Keum YS, Seo HJ, Chun KS, Lee SS, Surh YJ. Capsaicin suppresses phorbol ester-induced activation of NF-κB/Rel and AP-1 transcription factors in mouse epidermis. Cancer Lett 2001;164: 119-26.
45. Park KK, Surh YJ. Effects of capsaicin on chemically-induced twostage mouse skin carcinogenesis. Cancer Lett 1997;114:183-4.
46. Bhutani M, Pathak AK, Nair AS, et al. Capsaicin is a novel blocker of constitutive and interleukin-6-inducible STAT3 activation. Clin Cancer Res 2007;13:3024-32. (Pubitemid 46849579)
47. Chanda S, Erexson G, Frost D, Babbar S, Burlew JA, Bley K. 26-Week dermal oncogenicity study evaluating pure trans-capsaicin in Tg.AC hemizygous mice (FBV/N). Int J Toxicol 2007;26:123-33.
48. Knotkova H, Pappagallo M, Szallasi A. Capsaicin (TRPV1 agonist) therapy for pain relief: farewell or revival? Clin J Pain 2008;24: 142-54.
49. Shirakawa H, Yamaoka T, Sanpei K, Sasaoka H, Nakagawa T, Kaneko S. TRPV1 stimulation triggers apoptotic cell death of rat cortical neurons. Biochem Biophys Res Commun 2008;377:1211-5.
50. Yamaoka T, Yan F, Cao H, et al. Transactivation of EGF receptor and ErbB2 protects intestinal epithelial cells from TNF-induced apoptosis. Proc Natl Acad Sci U S A 2008;105:11772-7.